Issued Patents All Time
Showing 1–25 of 31 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11964973 | Substituted bicyclic compounds useful as T cell activators | Robert G. Gentles, Min Ding, Richard E. Olson, Scott W. Martin, Saumya Roy +4 more | 2024-04-23 |
| 11866430 | Naphthyridinone compounds useful as T cell activators | Louis S. Chupak, Min Ding, Robert G. Gentles, Yazhong Huang, Scott W. Martin +5 more | 2024-01-09 |
| 11713316 | Substituted naphthyridinone compounds useful as T cell activators | Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles, Yazhong Huang +16 more | 2023-08-01 |
| 11584747 | Substituted pyridopyrimidinonyl compounds useful as T cell activators | Richard E. Olson, Chetan Padmakar Darne, Bireshwar Dasgupta, Jayakumar Sankara Warrier, Hasibur Rahaman +3 more | 2023-02-21 |
| 11352360 | TGF-beta inhibitors | Todd Kinsella, Marina Gelman, Hui Hong, Ihab Darwish, Rajinder Singh +6 more | 2022-06-07 |
| 10961239 | TGF beta receptor antagonists | Robert M. Borzilleri, Chetan Padmakar Darne, Peiying Liu, Manjunatha Narayana Rao Kamble, Balaji Seshadri +3 more | 2021-03-30 |
| 10954238 | Substituted naphthyridinone compounds useful as T cell activators | Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles, Yazhong Huang +16 more | 2021-03-23 |
| 10669272 | Substituted naphthyridinone compounds useful as T cell activators | Louis S. Chupak, Chetan Padmakar Darne, Min Ding, Robert G. Gentles, Yazhong Huang +16 more | 2020-06-02 |
| 10287295 | TGF-β inhibitors | Todd Kinsella, Marina Gelman, Hui Hong, Ihab Darwish, Rajinder Singh +6 more | 2019-05-14 |
| 9981944 | GDF-8 inhibitors | Pingyu Ding, Marina Gelman, Todd Kinsella, Rajinder Singh, Somasekhar Bhamidipati +3 more | 2018-05-29 |
| 9956220 | Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors | Selvakumar Kumaravel, Arul Mozhi Selvan Subbiah Karupplah, Shilpa Holehatti Maheshwarappa, Chandrasekhar Reddy Rachamreddy, Mark D. Wittman | 2018-05-01 |
| 9884868 | TGF-beta inhibitors | Todd Kinsella, Marina Gelman, Hui Hong, Ihab Darwish, Rajinder Singh +6 more | 2018-02-06 |
| 9598423 | Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors | Chetan Padmakar Darne, Peiying Liu, Mark D. Wittman, Bradley C. Pearce, Erika M. V. Araujo +13 more | 2017-03-21 |
| 9556179 | Substituted imidazoles as casein kinase 1 D/E inhibitors | Chetan Padmakar Darne, Dharmpal S. Dodd, Anthony J. Sampognaro, Mark D. Wittman, Selvakumar Kumaravel +3 more | 2017-01-31 |
| 9475817 | Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors | Chetan Padmakar Darne, Dharmpal S. Dodd, Peiying Liu, Christopher P. Mussari, Mark D. Wittman +2 more | 2016-10-25 |
| 9273058 | Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors | Chetan Padmakar Darne, Peiying Liu, Mark D. Wittman, Bradley C. Pearce, Erika M. V. Araujo +13 more | 2016-03-01 |
| 9242967 | Substituted bicyclic heteroaryl compounds | Peiying Liu | 2016-01-26 |
| 9145419 | Imidazopyridazinyl compounds | Peiying Liu, James Aaron Balog | 2015-09-29 |
| 8916553 | Sulfonamide compounds useful as CYP17 inhibitors | Joel Francis Austin, Lisa S. Sharma, James Aaron Balog, Audris Huang, Chetan Padmakar Darne +1 more | 2014-12-23 |
| 8673922 | Azaindazole compounds | David B. Frennesson, Mark G. Saulnier, Joel Francis Austin, Audris Huang, James Aaron Balog +1 more | 2014-03-18 |
| 8592579 | Pyrrolotriazine kinase inhibitors | Mark D. Wittman, Harold Mastalerz, Kurt Zimmermann, Mark G. Saulnier, Dolatrai M. Vyas +6 more | 2013-11-26 |
| 8415340 | Triazine kinase inhibitors | Peiying Liu, Mark D. Wittman, David R. Langley | 2013-04-09 |
| 8212031 | Pyrrolotriazine kinase inhibitors | Dolatrai M. Vyas | 2012-07-03 |
| 8148522 | Intermediate useful in preparing certain pyrrolotriazine compounds and a process for making the intermediate | — | 2012-04-03 |
| 7879855 | Pyrrolotriazine kinase inhibitors | Mark D. Wittman, Harold Mastalerz, Kurt Zimmermann, Mark G. Saulnier, Dolatrai M. Vyas +6 more | 2011-02-01 |